KEY TRONIC CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data KEY TRONIC CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	468	446	464	449	519	544	605	567	468	387
Cost of revenue	429	412	429	414	477	501	558	527	431	363
Gross profit	38.3	34.2	34.6	35.2	42	43.2	47.5	39.9	36.4	23.9
Research and development	6.39	6.19	6.56	7.39	9.79	9.82	9.74	8.33	9.16	8.01
Selling, general and administrative	22.4	22.3	21.6	21	22.7	24.6	25.7	25.2	26.7	36.5
Operating expenses	28.8	33.1	40.6	28.4	32.5	34.4	31.1	33.1	35.9	38.7
Operating income	9.54	1.11	-5.96	6.83	9.53	8.8	16.3	6.76	0.56	-14.7
Interest expense	2.29	2.56	2.78	2.51	3.61	5.1	10	11.9	12.5	10.1
Pre-tax income	7.26	-1.44	-8.74	4.32	5.91	3.69	6.3	-5.19	-12	-24.8
Income tax	1.64	-0.12	-0.76	-0.44	1.57	0.31	1.14	-2.4	-3.64	23
Net income	5.62	-1.33	-7.98	4.76	4.34	3.38	5.16	-2.79	-8.32	-47.8
EBITDA	16.8	8.89	1.34	12.4	16.4	16.4	25.9	17.8	10.2	-4.49
EPS, basic	0.52	-0.12	-0.74	0.44	0.40	0.31	0.48	-0.26	-0.77	-4.41
EPS, diluted	0.51	-0.12	-0.74	0.44	0.39	0.31	0.47	-0.26	-0.77	-4.41
Shares, basic (weighted)	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.8
Shares, diluted (weighted)	10.9	10.8	10.8	10.8	11	11.1	10.9	10.8	10.8	10.8

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	0.37	0.34	0.6	0.55	3.47	1.71	3.6	4.75	1.38	0.58
Receivables	65.2	70.3	58.4	86.1	110	136	151	133	96.1	83.7
Inventory	102	110	100	115	137	156	138	105	97.3	95.8
Other current assets	11	13.6	16.5	17.3	23.3	24.7	27.5	24.7	21.9	19.5
Total current assets	178	195	198	243	299	340	350	288	234	224
Property, plant and equipment	30.5	27.5	29.4	31.8	35.7	26	28.9	28.8	27.7	28.9
Lease right-of-use assets			0	17.6	15.7	16.7	16.2	15.4	11.3	26.6
Goodwill	9.96	9.96	0
Intangible assets	4.8	3.73	0.66	0	0
Other non-current assets	2.41	2.9	2.3	2.59	1.46	14.1	11.4	5.35	19.2	19.2
Total assets	233	247	238	305	362	407	418	355	316	300
Accounts payable	53.1	76.2	73.6	80.2	92.8	121	116	79.4	63.7	76
Accrued liabilities	10	8.11	6.76	10.4	11.5	11.8	13.4	6.51	8.16	5.45
Short-term debt	5.84	5.84	5.84	7.51	2.14	2.19	3.14	3.12	6.22	7.16
Total current liabilities	77.8	98.9	93.4	112	127	164	152	104	92	106
Long-term debt	18.8					100	122	116	98.9	99.1
Lease liabilities			0	12.6	11.4	12	10.3	10.3	6.86	20.1
Other non-current liabilities	1.41	0.38	0	0.88	1.74	6	3.57	0.22	0.95	4.87
Total liabilities	116	128	124	189	238	282	288	231	199	231
Total debt	42.9	16.3	11.3	10	100	102	125	120	105	106
Retained earnings	73.5	72.8	65.4	70.1	74.5	77.8	83	76.9	68.6	20.8
Other comprehensive income	-2.78	-0.97	2.43	-1.5	2.07	-0.43	-0.1	-0.22	1.03	0.24
Shareholders' equity	117	118	114	116	124	125	131	124	117	69.2
Total equity	117	118	114	116	124	125	131	124	117	69.2
Total liabilities and equity	233	247	238	305	362	407	418	355	316	300
Shares outstanding	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.9

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	5.62	-1.33	-7.98	4.76	4.34	3.38	5.16	-2.79	-8.32	-47.8
Depreciation and amortization	7.23	7.77	7.3	5.59	6.86	7.56	9.54	11	9.6	10.2
Stock-based compensation	0.69	0.45	0.44	0.27	0.19	0.29	0.25	-0.44	0.22	0.63
Deferred income tax	-0.47	-1.56	-1.12	-0.96	-0.94	0.48	-1.99	-4.11	-6.6	22.4
Change in receivables	-5.1	-1.33	3.34	28.3	24.3	-25.6	-14.8	15.8	32.4	11.5
Change in inventory	4.92	-18.1	-1.42	14.7	23.1	-19.4	17.4	32.5	7.68	-1.83
Change in payables	-5.89	22.9	-2.63	6.63	12.6	28.6	-5.49	-36.5	-15.7	12.2
Cash from operations	2.28	3.12	0.92	-31	-15.1	-4.91	-11.3	13.8	18.9	4.42
Capital expenditures	-9.31	-4.52	-8.39	-8.62	-10.6	-6.81	-9.77	-3.96	-4.1	-6.35
Acquisitions	0
Cash from investing	-1.33	4.85	-1.91	-3.58	-10.6	-8.05	-4.53	-2.11	-4.2	-4.02
Debt repaid	-5.44	-5.87	-5.87	-7.12	-11.7	-2.14
Stock issued	0
Cash from financing	-1.6	-8.01	1.25	34.5	28.6	11.2	17.7	-10.5	-18.1	-1.21
Net change in cash	-0.65	-0.03	0.26	-0.05	2.92	-1.77	1.9	1.15	-3.37	-0.8
Free cash flow	-7.02	-1.4	-7.47	-39.6	-25.7	-11.7	-21.1	9.82	14.8	-1.93
Interest paid	2.24	2.53	2.77	2.48	3.78	5.11	9.26	10.3	11.1	9.54
Income taxes paid	1.8	0.3	-0.51	0.68	2.01	1.32	1.41	2.4	0.99	1.66

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $2.17 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	6.2%	Gross profit / revenue.
Operating margin	-3.8%	Operating income / revenue.
EBITDA margin	-1.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-6.4%	Pre-tax income / revenue.
Net margin	-12.4%	Net income / revenue.
FCF margin	-0.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	1.1%	Cash from operations / revenue.
Return on equity (ROE)	-51.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-15.5%	Net income / average total assets.
Return on invested capital (ROIC)	-5.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	2.1%	Research and development expense / revenue.
SG&A / revenue	9.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.6%	Capital expenditures / revenue.
D&A / revenue	2.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-17.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-13.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-5.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-34.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-20.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-10.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-2,719.0%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-144.2%	EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-76.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-113.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-40.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-19.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-11.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-10.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-3.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.10x	Current assets / current liabilities.
Quick ratio	0.79x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.01x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.54x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	35.4%	Total debt / total assets.
Liabilities / assets	76.9%	Total liabilities / total assets.
Net debt	$105.6M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-1.46x	Operating income / interest expense.
Working capital	$117.3M	Current assets - current liabilities.
Tangible book value	$69.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.26x	Revenue / average total assets.
Fixed asset turnover	13.7x	Revenue / average property, plant and equipment.
Inventory turnover	3.76x	Cost of revenue / average inventory.
Days inventory	97 days	365 x average inventory / cost of revenue.
Receivables turnover	4.30x	Revenue / average receivables.
Days sales outstanding	85 days	365 x average receivables / revenue.
Days payables	70 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	112 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	143.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$4.41	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$4.41	Net income per basic share, as reported (split-adjusted).
Revenue per share	$35.68	Revenue / diluted weighted shares.
FCF per share	-$0.18	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.41	Cash from operations / diluted weighted shares.
Book value per share	$6.37	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.37	Tangible book value / shares outstanding.
Cash per share	$0.05	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$23.6M	Share price x shares outstanding.
Enterprise value	$129.2M	Market cap + total debt - cash - short-term investments.
P/S	0.06x	Market cap / revenue.
P/B	0.34x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.34x	Market cap / tangible book value, when positive.
P/OCF	5.33x	Market cap / cash from operations, when positive.
EV/Sales	0.33x	Enterprise value / revenue.
FCF yield	-8.2%	Free cash flow / market cap.
Earnings yield	-202.8%	Net income / market cap (the inverse of P/E).

What was KEY TRONIC CORP's revenue in fiscal 2026?

KEY TRONIC CORP reported revenue of $386.7M for fiscal 2026, 17.4% lower than the year before.

Was KEY TRONIC CORP profitable in fiscal 2026?

No. It reported a net loss of $47.8M.

How much free cash flow did KEY TRONIC CORP generate in fiscal 2026?

Cash from operations of $4.4M minus capital expenditures of $6.4M left free cash flow of -$1.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to KEY TRONIC CORP